Botulinum Toxin vs Leuphasyl
A side-by-side research comparison of Botulinum Toxin and Leuphasyl across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Botulinum Toxin | Leuphasyl |
|---|---|---|
| Full name | Botulinum Toxin Type A (Botox) | Leuphasyl (Pentapeptide-18) |
| Category | Skin & Anti-Aging | Skin & Anti-Aging |
| Status | FDA-approved drug (prescription) | Research compound |
| Mechanism | Cleaves SNARE proteins (SNAP-25) required for acetylcholine release at the neuromuscular junction, temporarily blocking nerve signals to targeted muscles. This relaxes the muscle, softening dynamic wrinkles or reducing overactivity. | Binds enkephalin receptors on neuronal membranes, reducing calcium influx and neurotransmitter release at the presynaptic level. Works upstream of argireline. |
| Molecular weight | ~150 kDa | 599.7 Da |
| Half-life | Effects last ~3-4 months (local) | 6-10 hours (topical) |
| Bioavailability | Local intramuscular/intradermal injection | Moderate (topical) |
| Typical dose | Units per treatment area (clinical) | 3-5% solution |
| Frequency | Every ~3-4 months | 2x daily |
| Route | Injection by a professional | Topical |
Botulinum Toxin reported benefits
- Temporarily smooths dynamic wrinkles
- Treats muscle overactivity (medical)
- Reduces excessive sweating (medical)
- Migraine prevention (medical)
Leuphasyl reported benefits
- Complements argireline action
- Reduces muscle tension
- Smooths expression lines
- Gentle mechanism
Related comparisons
Research and educational reference only. Not medical advice.